Goldman Sachs’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $243M | Buy |
2,762,770
+1,602,598
| +138% | +$141M | 0.03% | 433 |
|
2025
Q1 | $106M | Sell |
1,160,172
-1,131,549
| -49% | -$103M | 0.02% | 656 |
|
2024
Q4 | $198M | Buy |
2,291,721
+194,720
| +9% | +$16.8M | 0.03% | 427 |
|
2024
Q3 | $199M | Buy |
2,097,001
+650,000
| +45% | +$61.8M | 0.03% | 446 |
|
2024
Q2 | $132M | Buy |
1,447,001
+100,000
| +7% | +$9.15M | 0.02% | 577 |
|
2024
Q1 | $122M | Sell |
1,347,001
-49,999
| -4% | -$4.53M | 0.02% | 587 |
|
2023
Q4 | $114M | Sell |
1,397,000
-250,971
| -15% | -$20.4M | 0.02% | 616 |
|
2023
Q3 | $132M | Buy |
1,647,971
+532,285
| +48% | +$42.5M | 0.03% | 508 |
|
2023
Q2 | $87.9M | Sell |
1,115,686
-484,213
| -30% | -$38.1M | 0.02% | 672 |
|
2023
Q1 | $124M | Sell |
1,599,899
-252,488
| -14% | -$19.6M | 0.03% | 522 |
|
2022
Q4 | $144M | Sell |
1,852,387
-249,870
| -12% | -$19.4M | 0.04% | 469 |
|
2022
Q3 | $141M | Buy |
2,102,257
+1,742,570
| +484% | +$117M | 0.04% | 461 |
|
2022
Q2 | $27.6M | Buy |
359,687
+212,560
| +144% | +$16.3M | 0.01% | 1386 |
|
2022
Q1 | $11.7M | Sell |
147,127
-209
| -0.1% | -$16.7K | ﹤0.01% | 2107 |
|
2021
Q4 | $11.3M | Buy |
147,336
+209
| +0.1% | +$16.1K | ﹤0.01% | 2174 |
|
2021
Q3 | $10.7M | Hold |
147,127
| – | – | ﹤0.01% | 2208 |
|
2021
Q2 | $10.7M | Sell |
147,127
-1,300,000
| -90% | -$95M | ﹤0.01% | 2200 |
|
2021
Q1 | $99.9M | Buy |
1,447,127
+1,227,000
| +557% | +$84.7M | 0.03% | 582 |
|
2020
Q4 | $14.6M | Hold |
220,127
| – | – | ﹤0.01% | 1795 |
|
2020
Q3 | $13.7M | Sell |
220,127
-44,373
| -17% | -$2.76M | ﹤0.01% | 1740 |
|
2020
Q2 | $16.5M | Hold |
264,500
| – | – | 0.01% | 1594 |
|
2020
Q1 | $14.4M | Sell |
264,500
-79,500
| -23% | -$4.32M | 0.01% | 1547 |
|
2019
Q4 | $22.1M | Sell |
344,000
-20,000
| -5% | -$1.28M | 0.01% | 1543 |
|
2019
Q3 | $20.7M | Buy |
364,000
+200,000
| +122% | +$11.4M | 0.01% | 1496 |
|
2019
Q2 | $9.62M | Sell |
164,000
-286,000
| -64% | -$16.8M | ﹤0.01% | 1965 |
|
2019
Q1 | $27.3M | Sell |
450,000
-250,012
| -36% | -$15.2M | 0.01% | 1402 |
|
2018
Q4 | $38.4M | Sell |
700,012
-100,116
| -13% | -$5.49M | 0.01% | 1123 |
|
2018
Q3 | $51.5M | Sell |
800,128
-8,961
| -1% | -$577K | 0.01% | 1070 |
|
2018
Q2 | $47.7M | Buy |
809,089
+158,363
| +24% | +$9.34M | 0.01% | 1105 |
|
2018
Q1 | $37M | Buy |
650,726
+400,591
| +160% | +$22.8M | 0.01% | 1216 |
|
2017
Q4 | $14.8M | Sell |
250,135
-100,800
| -29% | -$5.98M | ﹤0.01% | 1713 |
|
2017
Q3 | $20.3M | Buy |
350,935
+873
| +0.2% | +$50.4K | 0.01% | 1572 |
|
2017
Q2 | $20.7M | Sell |
350,062
-400,000
| -53% | -$23.6M | 0.01% | 1539 |
|
2017
Q1 | $41.4M | Buy |
750,062
+200,000
| +36% | +$11M | 0.01% | 1113 |
|
2016
Q4 | $28.9M | Sell |
550,062
-1,250,046
| -69% | -$65.6M | 0.01% | 1299 |
|
2016
Q3 | $103M | Buy |
1,800,108
+285,246
| +19% | +$16.4M | 0.03% | 582 |
|
2016
Q2 | $88.8M | Sell |
1,514,862
-4,942
| -0.3% | -$290K | 0.03% | 615 |
|
2016
Q1 | $87.4M | Buy |
1,519,804
+14,796
| +1% | +$851K | 0.03% | 624 |
|
2015
Q4 | $98.3M | Buy |
1,505,008
+359,211
| +31% | +$23.5M | 0.03% | 547 |
|
2015
Q3 | $72.2M | Buy |
1,145,797
+852
| +0.1% | +$53.7K | 0.02% | 621 |
|
2015
Q2 | $81M | Buy |
1,144,945
+692,032
| +153% | +$49M | 0.03% | 620 |
|
2015
Q1 | $31.8M | Buy |
452,913
+87,754
| +24% | +$6.16M | 0.01% | 1102 |
|
2014
Q4 | $23.5M | Sell |
365,159
-292,029
| -44% | -$18.8M | 0.01% | 1229 |
|
2014
Q3 | $41.8M | Buy |
657,188
+402,648
| +158% | +$25.6M | 0.01% | 887 |
|
2014
Q2 | $15.8M | Buy |
254,540
+200,900
| +375% | +$12.5M | ﹤0.01% | 1388 |
|
2014
Q1 | $3.13M | Sell |
53,640
-11,610
| -18% | -$678K | ﹤0.01% | 2296 |
|
2013
Q4 | $3.47M | Buy |
65,250
+100
| +0.2% | +$5.31K | ﹤0.01% | 2259 |
|
2013
Q3 | $3.12M | Sell |
65,150
-1,301
| -2% | -$62.2K | ﹤0.01% | 2221 |
|
2013
Q2 | $3.02M | Buy |
+66,451
| New | +$3.02M | ﹤0.01% | 2090 |
|